These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9350394)

  • 41. Evidence for postjunctional serotonin (5-HT1) receptors in the trigeminocervical complex.
    Goadsby PJ; Akerman S; Storer RJ
    Ann Neurol; 2001 Dec; 50(6):804-7. PubMed ID: 11761480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
    Deleu D; Hanssens Y
    Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry.
    Vishwanathan K; Bartlett MG; Stewart JT
    Rapid Commun Mass Spectrom; 2000; 14(3):168-72. PubMed ID: 10637423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-induced headaches.
    Dowson A
    Lancet; 1999 Jul; 354(9174):254-5. PubMed ID: 10421332
    [No Abstract]   [Full Text] [Related]  

  • 45. An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients.
    Pascual J; Muñoz R; Leira R
    Cephalalgia; 2001 Jul; 21(6):680-4. PubMed ID: 11531900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical pharmacokinetics of zolmitriptan.
    Dixon R; Warrander A
    Cephalalgia; 1997 Oct; 17 Suppl 18():15-20. PubMed ID: 9399013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials.
    Diener HC; Dowson AJ; Ferrari M; Nappi G; Tfelt-Hansen P
    Cephalalgia; 1999 Oct; 19(8):699-700. PubMed ID: 10570722
    [No Abstract]   [Full Text] [Related]  

  • 48. How effective are triptans in the treatment of episodic and chronic cluster headache.
    Millson DS
    Ital J Neurol Sci; 1999 Apr; 20(2 Suppl):S69-71. PubMed ID: 10662946
    [No Abstract]   [Full Text] [Related]  

  • 49. Zolmitriptan. Introduction.
    Mathew N
    Cephalalgia; 1997 Oct; 17 Suppl 18():1-3. PubMed ID: 9399011
    [No Abstract]   [Full Text] [Related]  

  • 50. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
    Limmroth V; Kazarawa Z; Fritsche G; Diener HC
    Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449
    [No Abstract]   [Full Text] [Related]  

  • 51. [Safety profile of 311C90 (zolmitriptan)].
    Morales Asín F
    Neurologia; 1998 Oct; 13 Suppl 2():25-30. PubMed ID: 9859692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Highly selective beginning. Associated symptoms and side effects in retrospect].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():107. PubMed ID: 14579499
    [No Abstract]   [Full Text] [Related]  

  • 53. Sumatriptan blocks spreading depression in isolated chick retina.
    Maranhão-Filho PA; Martins-Ferreira H; Vincent MB; Ribeiro LJ; Novis SA
    Cephalalgia; 1997 Dec; 17(8):822-5. PubMed ID: 9453269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitation of the 5HT1D agonists MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
    McLoughlin DA; Olah TV; Ellis JD; Gilbert JD; Halpin RA
    J Chromatogr A; 1996 Mar; 726(1-2):115-24. PubMed ID: 8900521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cerebrovascular serotonin antagonists and agonist among tropan derivatives].
    Gan'shina TS; Bezhanian SG; Kostochka LM; Volkova MIu; Mirsoian RS
    Eksp Klin Farmakol; 2008; 71(1):26-30. PubMed ID: 18365483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain.
    Dobson CF; Tohyama Y; Diksic M; Hamel E
    Cephalalgia; 2004 Jan; 24(1):2-11. PubMed ID: 14687006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CNS effects of sumatriptan and rizatriptan in healthy female volunteers.
    van der Post J; Schram MT; Schoemaker RC; Pieters MS; Fuseau E; Pereira A; Baggen S; Cohen AF; van Gerven JM
    Cephalalgia; 2002 May; 22(4):271-81. PubMed ID: 12100089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical efficacy of zolmitriptan in migraine].
    Leira R; Noya M
    Neurologia; 1998 Oct; 13 Suppl 2():16-24. PubMed ID: 9859691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical applications of zolmitriptan (Zomig, 311C90).
    Lipton RB; Stewart WF
    Cephalalgia; 1997 Oct; 17 Suppl 18():53-9. PubMed ID: 9399017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of hepatic impairment on the pharmacokinetics of zolmitriptan.
    Dixon R; French S; Kemp J; Sellers M; Leclerc V; Delvaux M; Rautureau J
    J Clin Pharmacol; 1998 Aug; 38(8):694-701. PubMed ID: 9725544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.